CorEvitas, LLC, United States
Disclosure information not submitted.
2F-03 - Benefits of Machine Learning Methods for Identifying Clinical Features and Patient Characteristics Associated with Treatment Outcomes in Autoimmune Conditions
Sunday, August 24, 20254:00 PM - 4:15 PM ET
6F-05 - Comparison of Performance of Common Exposure Episode Definitions in Long-Latency Outcome Studies
Tuesday, August 26, 20252:30 PM - 2:45 PM ET
